CN103816137B - The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius - Google Patents
The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius Download PDFInfo
- Publication number
- CN103816137B CN103816137B CN201310401654.0A CN201310401654A CN103816137B CN 103816137 B CN103816137 B CN 103816137B CN 201310401654 A CN201310401654 A CN 201310401654A CN 103816137 B CN103816137 B CN 103816137B
- Authority
- CN
- China
- Prior art keywords
- isophthalic acid
- methyl isophthalic
- avian influenza
- silica gel
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a kind of wood from the fire layer of & lt;I>Phellinus</ i>& lt;I> Igniarius</ i> (L The ex Fr.) Quel (split hoof wood layer hole bacteria & lt; i> phellinus< / i> & lt; i> Linteus< / i> (Berk et Curt) Teng , bowman's layer hole bacteria & lt; i> phellinus< / i> & lt; i> Baumii< / i> bacteria, harty needle hole & lt; i> phellinus< / i> & lt; i> Hartigii< / i> (Allesch Et Schnabl) Imaz) separation in the fermented liquid and fruiting body with avian flu activity of methyl benzodiazepines.The one that the present invention makes public for the first time methyl benzenediol is newly active, proves that it has anti virus H 5 N 1 of bird flu effect.The advantage that this method is applied compared with vague generalization compound is: found the new activity of this methyl benzenediol, proved that it has the effect of anti-avian influenza virus, and in birds production, the treatment of bird flu adds a kind of novel drugs.
Description
Technical field
The present invention relates to the extraction preparation method of active substance in a kind of phellinus igniarius of anti-avian influenza H5N1 virus, the phellinus igniarius strain particularly related to, be deposited in " China Committee for Culture Collection of Microorganisms's common micro-organisms " center "; deposit number is CGMCCNo.8108; specific name is phellinus igniarius Phellinusigniarius; preservation address is No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica on August 26th, 2013.
Background technology
Benzodiazepines can volatilize together with steam, it is strong reductant, meet naked light can burn, by high heat give out poisonous, be corrosive abnormal smells from the patient, can cause through skin poisoning, can distil, have stimulation to nervus centralis, respiratory system, rat oral LD50 is 3890mg/kg, different from resorcinol and hydroquinone.
At present, the medicament categories of anti-avian influenza virus mainly concentrates on monoclonal antibody, and kind is single, has certain limitation.
Summary of the invention
The invention discloses a kind of methyl benzenediol with anti-avian influenza activity be separated from medicinal fungus.The advantage that this method is applied compared with vague generalization compound is: the new activity having found this kind of methyl benzenediol, has the effect of anti-avian influenza virus.For anti-ball influenza virus provides new thinking and direction.
Technical scheme of the present invention is as follows:
First prepare phellinus igniarius crude extract, obtained by following method:
(1) fermentative medium formula in gram/100 milliliters be:
Corn starch 1-5% glucose 1-5%
Peptone 0.1-0.5% yeast extract 0.1-0.5%
Magnesium sulfate 0.1-0.5% potassium dihydrogen phosphate 0.01-0.05%
(2) be inoculated in conventional manner by phellinus igniarius strain and be equipped with in the conical flask of fluid medium, with 20 ~ 35 DEG C of temperature, shaking flask rotating speed is under 80 ~ 280r/min, pH3 ~ 8 conditions, vibrations cultivation 7 ~ 15 days; In cultivation when pH value drops to 2.5 ~ 4, seed in shaking flask is inoculated in the culture fluid of 50L fermentation tank, with temperature 20 ~ 35 DEG C, fermentation tank pressure 0.1 ~ 0.2 kg/cm, pH3 ~ 8, ventilation 0.5 ~ 1.1vvm, the condition that mixing speed is 100 ~ 280 revs/min, cultivate 7 ~ 15 days, the full liquid of phellinus igniarius mycelium fermentation can be utilized to prepare phellinus igniarius crude extract;
(3) get the full liquid of gained phellinus igniarius mycelium fermentation in step (2), by its concentrating under reduced pressure in a usual manner, make its volume concentration to 1/2 ~ 1/5 of original volume;
(4) by percent by volume be 60 ~ 95% ethanol concentrated to above-mentioned steps (3) after fermentation liquid extract, wherein, the amount adding ethanol is 2 ~ 8 times of concentrated solution volume, concentration of alcohol in extracting solution can be made to reach 60 ~ 90%, ethanol is preferably the edible ethanol of concentration 65-95%, and volume used is preferably the 3-6 of concentrated solution volume doubly;
(5) to step (4) gained extracting solution under 50 ~ 70 DEG C of conditions, heat 1 ~ 2 hour; Be separated in conventional manner, and remove impurity by cascade filtration, be separated and obtain ethanol extract; By above-mentioned ethanol extract concentrating under reduced pressure in a usual manner, make its volume concentration to 1/5 ~ 1/10 of original volume;
(6) just the concentrated solution of step (5) gained carries out drying with the method for frozen drying, obtains phellinus igniarius crude extract.
Then methyl benzenediol from phellinus igniarius crude extract, step is as follows: and phellinus igniarius crude extract → purification on normal-phase silica gel chromatography → chloroform and methanol elution gradient → TLC detect → purification on normal-phase silica gel chromatography → methanol gel chromatography → TLC detects → and purification on normal-phase silica gel chromatography → TLC detects → evaporated under reduced pressure → be 3-methyl isophthalic acid, 2-Benzodiazepines.
Concrete grammar is:
(1) phellinus igniarius crude extract is prepared;
(2) ethanol pellet of step (1) gained and purification on normal-phase silica gel are mixed stir, after drying, carry out silica normal phase column chromatography, use eluent 2-5 time, obtain eluent;
(3) by eluent evaporated under reduced pressure last in step (2), equal-volume silica gel mixed sample, carries out purification on normal-phase silica gel chromatography, uses eluent;
(4) collect the eluent that step (3) obtains, concentrating under reduced pressure, use dissolve with methanol, carry out methanol gel column chromatography, use eluent, use TLC to detect the eluent collected, suitably merge eluent, drying under reduced pressure;
(5) again carry out purification on normal-phase silica gel chromatography with the product that step 4 obtains, eluant is chloroform and methanol;
(6) TLC detects, and appropriateness merges eluent, and high-pressure drying, is methyl benzenediol.
Preferably, the sample silica gel of mixing described in extraction step (2) is 100-200 order purification on normal-phase silica gel, and chromatographic silica gel is positive 200-300 order, and eluant is chloroform and/or methanol;
Silica gel consumption described in extraction step (3) is equal-volume, and eluant is petroleum ether: acetone=20:1-40:1;
Gel described in extraction step (4) is SephadexLH-20, and eluant is methanol;
Eluant described in extraction step (5) is chloroform: methanol=100:1-150:1;
TLC described in extraction step (6) detects, and developing solvent is chloroform: methanol=25:1-40:1.
Example 1:
Phellinus igniarius crude extract, is obtained by following method:
(1) fermentative medium formula in gram/100 milliliters be:
Corn starch 1% glucose 1%
Peptone 0.1% yeast extract 0.1%
Magnesium sulfate 0.1% potassium dihydrogen phosphate 0.01%
(2) be inoculated in conventional manner by phellinus igniarius strain and be equipped with in the conical flask of fluid medium, with 25 DEG C of temperature, shaking flask rotating speed is under 110r/min, pH7 condition, vibrations cultivation 7 days; In cultivation when pH value drops to 3, seed in shaking flask is inoculated in the culture fluid of 50L fermentation tank, with temperature 25 DEG C, fermentation tank pressure 0.1 kg/cm, pH3, ventilation 0.5-1.1vvm, the condition that mixing speed is 100 revs/min, cultivate 7 days, the full liquid of phellinus igniarius mycelium fermentation can be utilized to prepare phellinus igniarius crude extract.
(3) get the full liquid of gained phellinus igniarius mycelium fermentation in step (2), by its concentrating under reduced pressure in a usual manner, make its volume concentration to 1/3 of original volume;
(4) by percent by volume be 70% ethanol concentrated to above-mentioned steps (3) after fermentation liquid extract, wherein, the amount adding ethanol is 5 times of concentrated solution volume, and concentration of alcohol in extracting solution can be made to reach 55%;
(5) to step (4) gained extracting solution under 70 DEG C of conditions, heat 1 hour; Be separated in conventional manner, and remove impurity by cascade filtration, be separated and obtain ethanol extract; By above-mentioned ethanol extract concentrating under reduced pressure in a usual manner, make its volume concentration to 1/5 of original volume;
(6) just the concentrated solution of step (5) gained carries out drying with the method for frozen drying, obtains phellinus igniarius crude extract.
Above-mentioned crude extract is taken 100g and equal-volume 100 order purification on normal-phase silica gel to mix and stir, carry out silica normal phase column chromatography.Chromatography immobile phase is 200-300 order purification on normal-phase silica gel, post height 0.8m, diameter 10cm, and eluant is for being respectively chloroform, and chloroform: methanol=100:1, distinguishes eluting 3,4 column volumes.And by gained eluent called after Fr-1, Fr-2 respectively.By Fr-2 equal-volume silica gel mixed sample, use silica gel to be 100 order purification on normal-phase silica gel, pentaploid amasss silica gel column chromatography, and the silica gel of use is 200-300 order purification on normal-phase silica gel.Eluant is petroleum ether: acetone=20:1.Concentrating under reduced pressure eluent, uses dissolve with methanol, methanol gel column chromatography.Use TLC to detect the eluent collected suitably to merge, evaporated under reduced pressure, carries out purification on normal-phase silica gel chromatography again, and eluant is chloroform and methanol, carries out TLC detection, suitably merges, high-pressure drying to eluent, carries out
1d-HNMR nuclear magnetic resonance spectroscopy, frequency is 400MHZ, and analysis result is δ 6.71 (s, 1H), 2.26 (s, 1H). prove as 3-methyl isophthalic acid, 2-Benzodiazepines.
(7) ergot sterone adopting step (6) to obtain carries out the mensuration to mdck cell toxicity, determines its median toxic concentration (CC
50) and maximum safe concentration.
On 96 orifice plates, 100 μ l/ holes add 4 × 10
5ml
-1the mdck cell suspension of concentration, after cultivating 24h, what cell monolayer added variable concentrations respectively contains sample maintenance medium, and often kind of concentration repeats 3 holes, and establishes normal cell controls.Put 37 DEG C, 5%CO
2after cultivating 48h in incubator, abandon culture fluid supernatant, 100 μ l/ holes add 5mg.ml
-1the maintenance medium of MTT, continue to cultivate after 1h, abandon MTT supernatant, every hole adds lysate (DMSO) 100 μ l, vibration 5-10min, to be crystallizedly dissolves completely, and microplate reader surveys the OD value at 492nm place.Calculate the median toxic concentration (CC of sample
50) and maximum safe concentration.As the OD of application of sample group
492value is not significantly lower than cell controls group OD
492time, this concentration is the maximum safe concentration of sample.
Table 13-methyl isophthalic acid, the impact of each concentration versus cell growth of 2-Benzodiazepines
Known by table 1: 3-methyl isophthalic acid, 2-Benzodiazepines maximum safe concentration is 25ug/mL.
Example 2:
Phellinus igniarius crude extract, is obtained by following method:
(1) fermentative medium formula in gram/100 milliliters be:
Corn starch 3% glucose 2%
Peptone 0.5% yeast extract 0.5%
Magnesium sulfate 0.5% potassium dihydrogen phosphate 0.05%
(2) be inoculated in conventional manner by phellinus igniarius strain and be equipped with in the conical flask of fluid medium, with 30 DEG C of temperature, shaking flask rotating speed is under 180r/min, pH6 condition, vibrations cultivation 15 days; In cultivation when pH value drops to 2.5, seed in shaking flask is inoculated in the culture fluid of 50L fermentation tank, with temperature 30 DEG C, fermentation tank pressure 0.2 kg/cm, pH3, ventilation 0.5-1.1vvm, the condition that mixing speed is 180 revs/min, cultivate 15 days, the full liquid of phellinus igniarius mycelium fermentation can be utilized to prepare phellinus igniarius crude extract.
(3) get the full liquid of gained phellinus igniarius mycelium fermentation in step (2), by its concentrating under reduced pressure in a usual manner, make its volume concentration to 1/5 of original volume;
(4) by percent by volume be 90% ethanol concentrated to above-mentioned steps (3) after fermentation liquid extract, wherein, the amount adding ethanol is 4 times of concentrated solution volume, and concentration of alcohol in extracting solution can be made to reach 70%;
(5) to step (4) gained extracting solution under 55 DEG C of conditions, heat 2.5 hours; Be separated in conventional manner, and remove impurity by cascade filtration, be separated and obtain ethanol extract; By above-mentioned ethanol extract concentrating under reduced pressure in a usual manner, make its volume concentration to 1/10 of original volume;
(6) just the concentrated solution of step (5) gained carries out drying with the method for frozen drying, obtains phellinus igniarius crude extract.
Above-mentioned crude extract is taken 100g and equal-volume 100 order purification on normal-phase silica gel to mix and stir, carry out silica normal phase column chromatography.Chromatography immobile phase is 200-300 order purification on normal-phase silica gel, post height 0.8m, diameter 10cm, and eluant is for being respectively chloroform, and chloroform: methanol=100:1, distinguishes eluting 3,4 column volumes.And by gained eluent called after Fr-1, Fr-2 respectively.By Fr-2 equal-volume silica gel mixed sample, use silica gel to be 100 order purification on normal-phase silica gel, pentaploid amasss silica gel column chromatography, and the silica gel of use is 200-300 order purification on normal-phase silica gel.Eluant is petroleum ether: acetone=40:1.Then methanol gel column chromatography is carried out.Again carry out purification on normal-phase silica gel chromatography, TLC detects the eluent collected and suitably merges, and drying under reduced pressure, carries out
1d-HNMR nuclear magnetic resonance spectroscopy, frequency is 400MHZ, and analysis result is δ 6.71 (s, 1H), 2.26 (s, 1H). prove as 3-methyl isophthalic acid, 2-Benzodiazepines.
(7) sample effect to H5N1 strain in mdck cell level is carried out, the half toxic concentration (CC of calculation sample within the scope of the maximum safe concentration adopting step (6) to obtain
50) and medium effective concentration (EC
50), obtain selection index (the SI)=CC of sample
50/ EC
50, calculate suppression ratio.
In test, arrange normal cell controls group (only adding cell maintenance medium), virus control group (only adding virus liquid), mass concentration is 2 times of dilutions, 4 mass concentrations in nontoxic scope, arrange 3 holes and repeat.Abandon 96 porocytes and cultivate supernatant in plate hole, 100 μ l/ holes add 10000TCID
50virus liquid (10
-4.43), 3 repetitions are set.37 DEG C of absorption 2h, abandon virus liquid supernatant, 100 μ l/ holes add the sample liquid of variable concentrations.Put 37 DEG C, 5%CO
2continue in incubator to cultivate 48h.Mtt assay is adopted to measure OD
492value, calculates medium effective concentration (EC
50).As the OD of application of sample group
492value is significantly greater than virus control group OD
492time, show that this sample liquid can significantly suppress viral infection MDCK, there is antiviral activity.
According to the cytopathy variability calculated and viral suppression.By the Probit Return Law of statistics software SPSS11.5, the half toxic concentration (CC of calculation sample
50) and medium effective concentration (EC
50), obtain selection index (the SI)=CC of sample
50/ EC
50.
According to lower formulae discovery viral suppression:
Viral suppression=(A-B)/(C-B) × 100%
A: sample liquid processed group OD value, B: virus control group OD value, C: cell controls group OD value
Table 2 compound is to the inhibitory action experimental result of H5N1 virus
Known by table 2: 3-methyl isophthalic acid, 2-Benzodiazepines can reach the suppression ratio of the highest 326.2% under 0.006109765625ug/ml concentration to H5N1 strain, now CC
50for 45.016ug/ml, EC
50for 14.2278ug/ml, SI are 25.
Claims (10)
1.3-methyl isophthalic acid, the application on anti-avian influenza H5N1 virus medicine prepared by 2-Benzodiazepines.
2. 3-methyl isophthalic acid as claimed in claim 1,2-Benzodiazepines, preparing the application on anti-avian influenza H5N1 virus medicine, is characterized in that 3-methyl isophthalic acid, and 2-Benzodiazepines extracts from phellinus igniarius, and extraction step order is as follows:
(1) phellinus igniarius crude extract is prepared;
(2) crude extract of step (1) gained and purification on normal-phase silica gel are mixed stir, after drying, carry out silica normal phase column chromatography, use eluent 2-5 time, obtain eluent;
(3) by eluent evaporated under reduced pressure last in step (2), equal-volume silica gel mixed sample, carries out purification on normal-phase silica gel chromatography, uses eluent;
(4) collect the eluent that step (3) obtains, concentrating under reduced pressure, use dissolve with methanol, carry out methanol gel column chromatography, use eluent, use TLC to detect the eluent collected, suitably merge eluent, drying under reduced pressure;
(5) again carry out purification on normal-phase silica gel chromatography with the product that step 4 obtains, eluant is chloroform and methanol;
(6) TLC detects, and appropriateness merges eluent, and high-pressure drying, is 3-methyl isophthalic acid, 2-Benzodiazepines.
3. 3-methyl isophthalic acid as claimed in claim 2, the application on anti-avian influenza H5N1 virus medicine prepared by 2 Benzodiazepiness, it is characterized in that described phellinus igniarius crude extract, obtained by following method:
(1) be inoculated in conventional manner by phellinus igniarius strain and be equipped with in the conical flask of fluid medium, with 20 ~ 35 DEG C of temperature, shaking flask rotating speed is under 80 ~ 280r/min, pH3 ~ 8 conditions, vibrations cultivation 7 ~ 15 days; In cultivation when pH value drops to 2.5 ~ 4, seed in shaking flask is inoculated in the culture fluid of 50L fermentation tank, with temperature 20 ~ 35 DEG C, fermentation tank pressure 0.1 ~ 0.2 kg/cm, pH3 ~ 8, ventilation 0.5 ~ 1.1vvm, the condition that mixing speed is 100 ~ 280 revs/min, cultivate 7 ~ 15 days, the full liquid of phellinus igniarius mycelium fermentation can be obtained;
(2) get the full liquid of gained phellinus igniarius mycelium fermentation in step (1), by its concentrating under reduced pressure in a usual manner, make its volume concentration to 1/2 ~ 1/5 of original volume;
(3) by percent by volume be 60 ~ 95% ethanol concentrated to above-mentioned steps (2) after fermentation liquid extract, wherein, the amount adding ethanol is 2 ~ 8 times of concentrated solution volume, and concentration of alcohol in extracting solution can be made to reach 60 ~ 90%;
(4) to step (3) gained extracting solution under 50 ~ 70 DEG C of conditions, heat 1 ~ 2 hour; Be separated in conventional manner, and remove impurity by cascade filtration, be separated and obtain ethanol extract; By above-mentioned ethanol extract concentrating under reduced pressure in a usual manner, make its volume concentration to 1/5 ~ 1/10 of original volume;
(5) concentrated solution of step (4) gained is carried out drying with the method for frozen drying, obtain phellinus igniarius crude extract.
4. 3-methyl isophthalic acid as claimed in claim 3, the application on anti-avian influenza H5N1 virus medicine prepared by 2 Benzodiazepiness, it is characterized in that described liquid culture based formulas in gram/100 milliliters be:
5. 3-methyl isophthalic acid as claimed in claim 3, the application on anti-avian influenza H5N1 virus medicine prepared by 2 Benzodiazepiness, it is characterized in that the ethanol of phellinus igniarius crude extract preparation process (3) is concentration 65%-95% edible ethanol, and volume used is 3-6 times of volume.
6. 3-methyl isophthalic acid as claimed in claim 2, the application on anti-avian influenza H5N1 virus medicine prepared by 2 Benzodiazepiness, it is characterized in that, sample silica gel of mixing described in step (2) is 100-200 order purification on normal-phase silica gel, chromatographic silica gel is positive 200-300 order, and eluant is chloroform and/or methanol.
7. 3-methyl isophthalic acid as claimed in claim 2,2 Benzodiazepiness, preparing the application on anti-avian influenza H5N1 virus medicine, is characterized in that, the silica gel consumption described in step (3) is equal-volume, and eluant is petroleum ether: acetone=20:1-40:1.
8. 3-methyl isophthalic acid as claimed in claim 2,2 Benzodiazepiness, preparing the application on anti-avian influenza H5N1 virus medicine, is characterized in that, the gel described in step (4) is SephadexLH-20, and eluant is methanol.
9. 3-methyl isophthalic acid as claimed in claim 2,2 Benzodiazepiness, preparing the application on anti-avian influenza H5N1 virus medicine, is characterized in that, the eluant described in step (5) is chloroform: methanol=100:1-150:1.
10. 3-methyl isophthalic acid as claimed in claim 2,2 Benzodiazepiness, preparing the application on anti-avian influenza H5N1 virus medicine, is characterized in that, the TLC described in step (6) detects, and developing solvent is chloroform: methanol=25:1-40:1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310401654.0A CN103816137B (en) | 2013-09-06 | 2013-09-06 | The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310401654.0A CN103816137B (en) | 2013-09-06 | 2013-09-06 | The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103816137A CN103816137A (en) | 2014-05-28 |
| CN103816137B true CN103816137B (en) | 2016-01-20 |
Family
ID=50751625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310401654.0A Expired - Fee Related CN103816137B (en) | 2013-09-06 | 2013-09-06 | The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816137B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106562939B (en) * | 2015-10-08 | 2019-01-15 | 中国科学院微生物研究所 | Application of the compound AJ-4 in the drug that preparation treats or prevents influenza virus |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603577A (en) * | 2011-01-19 | 2012-07-25 | 董慧珍 | Derivatives of anti-influenza and anti-avian influenza medicament and application thereof |
| CN103073551A (en) * | 2013-01-30 | 2013-05-01 | 青岛农业大学 | Separation technology for cyclic dipeptide C2 in phellinus igniarius |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5436272B2 (en) * | 2010-03-02 | 2014-03-05 | 株式会社三谷バルブ | Aerosol cover body and aerosol type product provided with this aerosol cover body |
-
2013
- 2013-09-06 CN CN201310401654.0A patent/CN103816137B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603577A (en) * | 2011-01-19 | 2012-07-25 | 董慧珍 | Derivatives of anti-influenza and anti-avian influenza medicament and application thereof |
| CN103073551A (en) * | 2013-01-30 | 2013-05-01 | 青岛农业大学 | Separation technology for cyclic dipeptide C2 in phellinus igniarius |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103816137A (en) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106278877B (en) | A kind of novel structure sesquiterpenoid and its application in preparing anti-inflammatory drugs | |
| CN105925635A (en) | Production process of icariside II | |
| CN101492706A (en) | Method for improving cordyceps sinensis bacterium native volume of production with cordyceps militaris link liquid fermentation | |
| CN109749941B (en) | Paecilomyces cicadae fermentation medium and method for preparing ergosterol by fermenting Paecilomyces cicadae | |
| CN103816137B (en) | The application of methyl benzenediol on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN108640956A (en) | A method of preparing flavonoid glycoside from tea seed | |
| CN103800331B (en) | The application of Cyclic dipeptides C7 on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103800330B (en) | The application of Cyclic dipeptides C5 on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103816138B (en) | The application of 1,2-Benzodiazepines on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103816140B (en) | The application of methyl acetophenone on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103800332B (en) | In phelliuns igniarius, encircle the application of dipeptides C6 on anti-avian influenza H5N1 virus | |
| CN103816156B (en) | The application of Cyclic dipeptides C2 on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103800321B (en) | In phelliuns igniarius 1, the application of 2-eudesmane type sesquiterpene on anti-avian influenza H5N1 virus | |
| CN103816163B (en) | Ergot sterone application in anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN105274152B (en) | Curcumin biotransformation method, product and application | |
| CN104231011A (en) | Preparation method of verbascoside | |
| CN110804036B (en) | Flavone derivative and preparation method and application thereof | |
| CN103816139B (en) | The application of DHAP on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN103800333B (en) | The application of Cyclic dipeptides C8 on anti-avian influenza H5N1 virus in phellinus igniarius | |
| CN105695544A (en) | Method for extracting cyclo(Pro-Gly)dipeptide from Bacillus coagulans | |
| CN104807925A (en) | Method for extracting and separating allelopathic autotoxicity substances from panax notoginseng rhizosphere soil | |
| CN101912148B (en) | Extraction method for blackberry lily extractum and application of blackberry lily extractum in cigarettes | |
| CN105837590A (en) | Compound with anti-Candida albicans activity, preparation method and application thereof | |
| CN103800329B (en) | Cyclic dipeptides C1 application in the medicine preparing anti-avian influenza H5N1 virus in phelliuns igniarius | |
| CN102505024B (en) | Method for preparing prednisolone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160120 Termination date: 20160906 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |